Internet Stroke Center Home Stroke Trials Registry
 
National Institute of Neurological Disorders & Stroke
American Stroke Association
Washington University School of Medicine
 
 Trials Directories
Ongoing Trials
Completed Trials
Acute Stroke Trials
Hemorrhage Trials
Prevention Trials
Recovery Trials
 Interventions
Drugs - By Name
Drugs - By Category
Procedures
Recovery Therapies
 Assessment Scales
Specific Stroke Scales
Stroke Scales Overview
 Stroke Trial Links
Government Sites
Independent Sites
 News & Updates
Update List
General Stroke News
About this Site
Submit Your Trial
Send Feedback

 Search for Trials

PubMed
We comply with the "Health on the Net" (HON) code of standards for trustworthy health information: verify here.



 
Stroke Interventions in Clinical Trials
Printable Version
Acetaminophen for Altering Body Temperature in Acute Stroke



Principal Investigator
Scott E. Kasner, M.D.

PI Address
Department of Neurology
Comprehensive Stroke Center
University of Pennsylvania Medical Center
3W Gates Bldg
3400 Spruce St.
Philadelphia, PA 19104

Sponsor



Trial Phase:Phase I
Study Size Actual:39
Centers Actual:2
Centers Planned:2
Max Time from onset:24 Hours
Follow-up Duration:24 Hours
Status:
Trial complete. Results published January 2002.

Purpose:
To assess the efficacy of regularly administered acetaminophen in modifying core body temperature of awake, afebrile acute stroke patients over 24 hours.

Interventions:
Acetaminophen
Anti-pyretic analgesic; potent inhibitor of hemoprotein-catalyzed lipid peroxidatrion with an IC50 for hemoglovin of 15uM, which is in the range of plasma levels resulting from therapeutic doses of the drug in humans. It acts by reducing the ferryl-oxo radical form of the heme, and thereby prevents formation of the hemoprotein radical that initiates lipid peroxidation.

Location(s):
University of Pennsylvania
University of Texas-Houston

Year Started: 1997
Year Finished: 2001
Year Published: 2002


Design:
Randomized controlled clinical trial with 39 patients at 2 university hospitals.

Inclusion Criteria
Patients presenting with evidence of acute ischemic stroke or hemorrhagic stroke within 24 hours, NIHSS score greater than or equl to 5, core body temperature less than 38.5 degrees C, white blood cell count less then 12.6x10 (3) cells/mm(3).

Exclusion Criteria
Clinical or radiological signs of infection, severe medical illnesses, known contraindication or hypersensitivity to acetaminophen, known contraindication to placement of a urinary catheter, or participation in another interventional clinical trial for acute stroke.

Patient Involvement:
Patients received either acetaminophen 650 mg or placebo every 4 hours for 24 hours (7 doses, 4550 mg total). Core body temperature was measured every 30 minutes via temperature-sensing catheter in the urinary bladder.

Primary Outcome:
Mean core body temperature during the 24 hour study.

Secondary Outcome:
Change in NIHSS.

Results:
Early administration of 650 mg acetaminophen every 4 hours did not result in a statistically significant reduction in core body temperature.

Source of Information:
Stroke. 2002;33:130-135.

Web Links and Publications:
Acetaminophen for altering body temperature in acute stroke: a randomized clinical trial.
Stroke 2002 Jan;33(1):130-4

This information last updated on: 5/2/2003

UID: 501

   

Internet Stroke Center at Washington University:
HOME | ABOUT | PRIVACY POLICY | CONTACT

Copyright © 1997-2009 - Internet Stroke Center. All rights reserved.                                           Last modified: Friday, November 20, 2009